Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gastric Ultrasound To Assess Gastric Contents In Patients On Semaglutide Therapy

NCT06292065 is registered in ClinicalTrials.gov with Nils Vlaeminck as lead sponsor.

NCT NCT06292065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06292065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gastric Ultrasound To Assess Gastric Contents In Patients On Semaglutide Therapy
Lead sponsor
Nils Vlaeminck
Phase
Not applicable
Overall status
Completed
Start date
April 16, 2024
Completion date
May 31, 2025
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroparesis